NEW YORK, April 17, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Deep Brain Stimulation Devices Market for Parkinson's Disease (North America, Europe, Asia-Pacific and Latin America) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
A rise in the world's aging population, increase in the number of patients living with Parkinson's disease and growing awareness about neurological movement disorders among patients have triggered the growth of deep brain stimulation devices market. Globally, neurological disorders are the main causes of mortality; these account for approximately 12% of total number of deaths. Of these, cerebrovascular diseases are responsible for 85% of deaths. Parkinson's disease is the most common neurodegenerative movement disorder after Alzheimer's. Symptoms associated with this disease include tremors, slowness of movement, muscle stiffness and trouble with balance.
Drug therapy is the most effective treatment option available to control Parkinson's disease in the initial stages; however, a large number of medicines are required to control the disease during the advanced stages. In late stage of the disease, deep brain stimulation (DBS) surgical treatment is used to control the involuntary symptoms. DBS is an effective, clinically proven and the U.S. FDA approved advanced surgical option to treat mild to severe Parkinson's disease. The market for DBS devices is expected to grow at a healthy rate during the forecast period of 2013 to 2019. However, high cost involvement in the surgical procedure may hamper the growth of the market. A growing burden of Parkinson's disease on the healthcare system coupled with uncertain economic conditions in the U.S. and Europe has forced Original Equipment Manufacturers (OEMs) to develop cost-effective devices for the treatment of neurological movement disorders.
The research report on DBS devices that are used to treat Parkinson's disease provides a detailed analysis of the global market and helps in understanding the driving forces responsible for the growth of the market. The report discusses the DBS devices market for Parkinson's disease on the basis of prevalence of the disease in four regions: North America, Europe, Asia Pacific and Latin America.
The global DBS devices market for Parkinson's disease has been segmented with respect to geography. Market size estimates and forecasts for the period of 2011 to 2019 have been provided for each of the geography in terms of USD billion, considering 2012 as the base year for calculations and 2011 as the historical year. The CAGR (%) of each market segment for the forecast period 2013 to 2019 has also been provided along with market size estimations.
The market overview section provides a detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global DBS devices market for the treatment of Parkinson's disease. The section also covers opportunities and market attractiveness analysis for market participants.
The report concludes with the competitive landscape and company profiles of major market players. These market players have been profiled on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Prominent players in the market that are profiled in the report include Medtronic, Inc., St. Jude Medical, Inc. and Boston Scientific Corporation. Other players that are covered in the report are Sapiens Neuro and Aleva Neurotherapeutics SA. DBS products of these companies are not yet commercially available in the market. (segue...) Fonte: PRNewsWire.